Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Endobronchial Ultrasound Needle Designed to Retrieve Lymph Node Cell, Tissue Samples

By Medimaging International staff writers
Posted on 27 Feb 2014
Print article
Image: Cook Medical’s EchoTip ProCore endobronchial ultrasound (EBUS) needles (Photo courtesy of Cook Medical).
Image: Cook Medical’s EchoTip ProCore endobronchial ultrasound (EBUS) needles (Photo courtesy of Cook Medical).
A new endobronchial ultrasound (EBUS) needle gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumors in the pulmonary region.

Cook Medical’s (Bloomington, IN, USA) EchoTip ProCore EBUS needle is a single-use needle that collects cell and tissue samples for the diagnosis of lung cancer and various mediastinal diseases. The needle can be used for fine-needle biopsy of lesions of submucosal and extramural lesions within or adjacent to the tracheobronchial tree or gastrointestinal tract.

Prior to the availability of the EchoTip ProCore EBUS needle, tissue samples from the pulmonary area could be obtained only by surgical methods. Minimally invasive procedures could obtain cell samples only through fine needle aspiration. The EchoTip ProCore EBUS needle is designed with a core-trap technology that allows physicians to collect tissue samples through a minimally invasive procedure.

“Cook’s ProCore technology has already proven itself in the GI endoscopic ultrasound space,” said Barry Slowey, global leader of Cook Medical’s endoscopy division. “We are so pleased that physicians can now use the same technology in the pulmonary area, and we hope that this technology will aid in quick and accurate diagnosis for patients.”

Moreover, Cook recently introduced the 25-gage EchoTip Ultra endobronchial ultrasound needle, which is 33% more flexible than the 22-gage needle. This feature allows physicians to deflect the endoscope to a greater level than is possible with larger needles. The added flexibility can also allow physicians to reach more pulmonary target lesions.

Related Links:

Cook Medical



Print article
Radcal

Channels

Industry News

view channel

Mallinckrodt to Sell Nuclear Imaging Business to IBA Molecular

Mallinckrodt plc (Dublin, Ireland) has entered into a definitive agreement to sell its nuclear imaging business to IBA Molecular (IBAM) (Sterling, VA, USA) for approximately USD 690 million. Mallinckrodt develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies,... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.